Young CW - Search Results

1

Treatment of refractory adult lymphoblastic leukemia (ALL) with 4'(9-acridinylamino) methanesulfon-M-anisidide (AMSA).

Arlin ZA, Fanucchi MP, Gee TS, Kempin SJ, Mertelsmann R, Young CW, Clarkson BD. Arlin ZA, et al. Among authors: young cw. Blood. 1982 Nov;60(5):1224-6. Blood. 1982. PMID: 6957250 Free article.

2

Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanine.

Arlin ZA, Flomenberg N, Gee TS, Kempin SJ, Dellaquila C, Mertelsmann R, Straus DJ, Young CW, Clarkson BD. Arlin ZA, et al. Among authors: young cw. Cancer Clin Trials. 1981 Fall;4(3):317-21. Cancer Clin Trials. 1981. PMID: 6895190

3

Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia.

Arlin ZA, Sklaroff RB, Gee TS, Kempin SJ, Howard J, Clarkson BD, Young CW. Arlin ZA, et al. Among authors: young cw. Cancer Res. 1980 Sep;40(9):3304-6. Cancer Res. 1980. PMID: 6933002

4

Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia.

Warrell RP Jr, Arlin ZA, Kempin SJ, Young CW. Warrell RP Jr, et al. Among authors: young cw. Cancer Treat Rep. 1982 Aug;66(8):1619-23. Cancer Treat Rep. 1982. PMID: 6955022

5

Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia.

Warrell RP Jr, Arlin ZA, Gee TS, Chou TC, Roberts J, Young CW. Warrell RP Jr, et al. Among authors: young cw. Cancer Treat Rep. 1982 Jul;66(7):1479-85. Cancer Treat Rep. 1982. PMID: 7046929 Clinical Trial.

6

Effectiveness of methyl-GAG (methylglyoxal-bis[guanylhydrazone]) in patients with advanced malignant lymphoma.

Warrell RP Jr, Lee BJ, Kempin SJ, Lacher MJ, Straus DJ, Young CW. Warrell RP Jr, et al. Among authors: young cw. Blood. 1981 Jun;57(6):1011-4. Blood. 1981. PMID: 7013854 Free article.

7

Multidisciplinary treatment of advanced Hodgkin's disease by an alternating chemotherapeutic regimen of MOPP/ABDV and low-dose radiation therapy restricted to originally bulky disease.

Young CW, Straus DJ, Myers J, Passe S, Nisce LZ, Lee BJ, Koziner B, Arlin Z, Kempin S, Gee T, Clarkson BD. Young CW, et al. Cancer Treat Rep. 1982 Apr;66(4):907-14. Cancer Treat Rep. 1982. PMID: 7042090 Clinical Trial.

8

The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease: a follow-up report.

Straus DJ, Myers J, Passe S, Young CW, Nisce LZ, Lee BJ, Koziner B, Arlin Z, Kempin S, Gee T, Clarkson BD. Straus DJ, et al. Among authors: young cw. Cancer. 1980 Jul 15;46(2):233-40. doi: 10.1002/1097-0142(19800715)46:2<233::aid-cncr2820460202>3.0.co;2-c. Cancer. 1980. PMID: 6155987 Clinical Trial.

9

Phase II trial of vindesine in patients with acute leukemia.

Sklaroff RB, Arlin Z, Young CW. Sklaroff RB, et al. Among authors: young cw. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2063-5. Cancer Treat Rep. 1979. PMID: 294307

10

Effect of very high-dose thymidine infusions on leukemia and lymphoma patients.

Blumenreich MS, Woodcock TM, Andreeff M, Hiddemann W, Chou TC, Vale K, O'Hehir M, Clarkson BD, Young CW. Blumenreich MS, et al. Among authors: young cw. Cancer Res. 1984 May;44(5):2203-7. Cancer Res. 1984. PMID: 6713407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters